Why does artificial intelligence need regulation?
Mike & Amit discuss the shifting landscape of AI law and the legislation to expect in 2024...
25 November 2021 in Podcasts
Oculis CEO Riad Sherif talks about the importance of expert investors, community engagment and setting the agenda in the Biotech industry After reaching the top of the pharmaceutical industry, his urge to join...
Apple Google SpotifyRiad Sherif is a true expert in his field. Trained as a doctor, his drive to succeed in business led him to pharmaceuticals and a successful 25-year career at corporate giants like Sanofi and Novartis.
In 2017, he joined the Swiss startup Oculis and as CEO he’s steered the biotech company to financial and regulatory success.
Oculis is developing a non-invasive treatment for diabetes-induced blindness which, if successful, could improve access to care for millions. In May, the company secured a $57 million financing round enabling it to expand its groundbreaking medical research.
In conversation with IMD President Jean-Francois Manzoni, Riad Sherif talks about the importance of expert investors, how engaging with the community can build your professional network, and why you should never take a meeting without an agenda.
Credits:
Host: IMD President Jean-François ManzoniÂ
Guest: Riad Sherif
Produced by JohnJo Devlin
18 April 2024 • by Michael R. Wade, Amit M. Joshi in Podcasts
Mike & Amit discuss the shifting landscape of AI law and the legislation to expect in 2024...
16 April 2024 • by Amit M. Joshi in Podcasts
Chris Tung is President of Strategic Development at Chinese e-commerce multinational Alibaba Group. He tells Amit Joshi how the company is integrating AI to optimize its customer experience....
11 April 2024 • by Raphaël Grieco, Karl Schmedders in Podcasts
Chris Douvos talks Chris discusses the impact of innovative fund structures, data utilization, and institutional interest. ...
5 April 2024 • by Michael R. Wade, Amit M. Joshi in Podcasts
Mike & Amit discuss how artificial intelligence may revolutionize healthcare, and improve our collective quality of life...
Explore first person business intelligence from top minds curated for a global executive audience